We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
+$557M
(+1.4%)
Cap. Flow
+$599M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
791
New
88
Increased
233
Reduced
320
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$977M |
| 2 |
Lockheed Martin
LMT
|
+$187M |
| 3 |
Kimberly-Clark
KMB
|
+$149M |
| 4 |
CELG
Celgene Corp
CELG
|
+$142M |
| 5 |
Under Armour Class C
UA
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$781M |
| 2 |
RTN
Raytheon Company
RTN
|
+$186M |
| 3 |
Costco
COST
|
+$133M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.18% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
STMicroelectronics
STM
$46.7B
| $8.35M | 0.02% |
431,800
+10,000
| +2% | +$183K |
|
|
BLU
552
DELISTED
BELLUS Health Inc.
BLU
| $8.31M | 0.02% |
+1,300,000
| New | +$9.17M |
|
553
Qorvo
QRVO
$7.99B
| $8.3M | 0.02% |
111,978
+48,700
| +77% | +$3.54M |
|
|
BDSI
554
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $8.21M | 0.02% |
1,950,000
+500,000
| +34% | +$2.14M |
|
555
ProPetro Holding
PUMP
$1.36B
| $8.18M | 0.02% |
900,264
-349,423
| -28% | -$4.85M |
|
|
JNPR
556
DELISTED
Juniper Networks
JNPR
| $8.17M | 0.02% |
330,000
-88,900
| -21% | -$2.24M |
|
|
KALV
557
DELISTED
KalVista Pharmaceuticals
KALV
| $8.12M | 0.02% |
700,000
| – | – |
|
|
P
558
Everpure Inc
P
$25.7B
| $8.05M | 0.02% |
+475,000
| New | +$7.45M |
|
|
COHR
559
DELISTED
Coherent Inc
COHR
| $8.02M | 0.02% |
52,200
+1,800
| +4% | +$260K |
|
560
Pinterest
PINS
$13.4B
| $7.93M | 0.02% |
300,000
+100,000
| +50% | +$3M |
|
561
DXC Technology
DXC
$1.82B
| $7.93M | 0.02% |
268,876
-61,400
| -19% | -$2.62M |
|
562
Invesco
IVZ
$13.1B
| $7.9M | 0.02% |
466,269
-4,300
| -0.9% | -$75.9K |
|
|
SEE
563
DELISTED
Sealed Air
SEE
| $7.8M | 0.02% |
+187,975
| New | +$7.96M |
|
|
ATRI
564
DELISTED
Atrion Corp
ATRI
| $7.79M | 0.02% |
+10,000
| New | +$7.76M |
|
565
FMC
FMC
$1.34B
| $7.77M | 0.02% |
+88,638
| New | +$7.61M |
|
566
Rayonier Advanced Materials
RYAM
$604M
| $7.77M | 0.02% |
1,794,341
+400,000
| +29% | +$1.71M |
|
|
PRSP
567
DELISTED
Perspecta Inc. Common Stock
PRSP
| $7.76M | 0.02% |
297,168
+85,757
| +41% | +$2.1M |
|
|
CBAY
568
DELISTED
Cymabay Therapeutics
CBAY
| $7.68M | 0.02% |
1,500,000
| – | – |
|
569
Camden Property Trust
CPT
$11B
| $7.66M | 0.02% |
+69,000
| New | +$7.43M |
|
570
IDEX
IEX
$17B
| $7.64M | 0.02% |
+46,600
| New | +$7.73M |
|
|
RETA
571
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.63M | 0.02% |
95,000
+50,000
| +111% | +$4.24M |
|
572
MeiraGTx Holdings
MGTX
$1.09B
| $7.58M | 0.02% |
475,000
+300,000
| +171% | +$6.98M |
|
573
Precision BioSciences
DTIL
$180M
| $7.56M | 0.02% |
30,043
| – | – |
|
574
10x Genomics
TXG
$6B
| $7.56M | 0.02% |
+150,000
| New | +$8.3M |
|
|
TPTX
575
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $7.52M | 0.02% |
200,000
| – | – |
|
Similar funds
Adage Capital Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Adage Capital Partners held 791 positions worth $40.7B, up 1.4% from $40.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners's Q3 2019 filing shows 88 new, 233 increased, 320 reduced and 78 closed positions. Its largest new stake was Kimberly-Clark: 1,083,253 shares worth $154M. The largest sale was Anadarko Petroleum, an estimated $781M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Adage Capital Partners's largest Q3 2019 buy was Kimberly-Clark: 1,083,253 shares worth $154M.
- Adage Capital Partners added most to Allergan plc in Q3 2019, an estimated $977M increase.
- Adage Capital Partners's biggest Q3 2019 reduction was Costco, cutting an estimated $133M.
- Adage Capital Partners fully exited Anadarko Petroleum in Q3 2019, selling an estimated $781M.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q3 2019.
- Adage Capital Partners opened 88 new positions and closed 78 in Q3 2019.
- Adage Capital Partners's portfolio value rose 1.4% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.